UNSPSC 51451611: Subendazole

This classification denotes an antihelminthic agent with the molecular formula C10H5Cl3N4S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YT3IDN1WR0, chemically known as 4,5,7-trichloro-2-((3-(methylthio)-1,2,4-thiadiazol-5-yl)thio)benzimidazole but generally known as subendazole, which bears US NIH Compound Identifier 213015. European Medicines Agency schedules Subendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10662MIG.

UNSPSC 51451611 Subendazole, a Commodity code, does not align with the recent state and local contract opportunities tagged under it. The solicitations in the active block — naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for fire rescue, and generic pharmaceuticals distributed through authorized wholesalers — concern naloxone products, opioid-response initiatives, emergency medical consumables, and broad pharmaceutical procurement, none of which involve subendazole (a veterinary anthelmintic agent). State and local governments show little documented recent activity under this specific code, and the few records present appear to reflect tagging misalignment rather than genuine subendazole demand.

The issuing bodies in the recent records span state health and human services departments (Texas HHS Commission), county health agencies (Seminole County, Florida), municipal fire departments (City of Tampa), and multistate cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance, which includes Oregon participants). The geographic spread covers Texas, Florida, Minnesota, and Oregon, reflecting scattered state and local engagement with pharmaceutical and medical supply procurement broadly. The most concrete recent opportunity is Seminole County's IFB60459723LAS, posted June 30, 2026, with a July 26, 2026 response deadline, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health initiatives. The City of Tampa issued ITB 26P00145 on March 25, 2026 for medical and first aid supplies with a March 13, 2026 response deadline and an estimated contract value of $700,000, designated as a sheltered market opportunity for certified Small Local Business Enterprises. Business development professionals should treat this code as inactive for subendazole procurement and verify correct UNSPSC assignment before pursuing opportunities under it.